跳至主要内容
临床试验/NL-OMON51271
NL-OMON51271招募中不适用

A multi-center observational study on the Prevalence of Loss of benefit after DBS for medication-refractory tremor - Loss of benefit after DBS in tremor patients

Academisch Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients of any age over 18 who are capable of understanding and granting
  • informed consent.
  • 2. Patients who have undergone unilateral or bilateral DBS surgery for
  • medication-refractory upper extremity tremor at least 5 years prior to
  • recruitment. The upper limit for the time since surgery will be 15 years. Long
  • intervals are specifically welcome.
  • 3. Preoperative diagnosis of ET, ET plus or isolated dystonic tremor as defined
  • by the tremor task force of the international Parkinson and Movement Disorders
  • Society consensus in 2018 (Bhatia et al., 2018).
  • 4. Availability of retrospective clinical baseline and early postoperative
  • data, including tremor scales (see below 4.3.4).
  • 5. Stable tremor medications and stimulation settings for at least 2 months
  • prior to the study visit.
  • 6. Patients must be able to follow the assessment procedure.

排除标准

  • 1. Concomitant diseases that may confound the neurological findings.
  • 2. DBS hardware malfunction (e.g., battery or electrode failure).
  • 3. Significant cognitive impairment that may make patient unable to follow
  • assessment procedure.

研究者

相似试验